Companies: 49,260 Total Market Cap: 131872101107354.76

Smruthi Organics Limited

BOM-540686
Medicinal Chemicals and Botanical Products
Rank #36280
Market Cap 18.35 M
Volume 7,512
Price 1.58
Change (%) 3.19%
Country or region India India

Smruthi Organics Limited's latest marketcap:

18.35 M

As of 05/22/2025, Smruthi Organics Limited's market capitalization has reached $18.35 M. According to our data, Smruthi Organics Limited is the 36280th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 18.35 M
Revenue (ttm) 14.65 M
Net Income (ttm) 414,365.27
Shares Out 11.45 M
EPS (ttm) 0.04
Forward PE 0.00
Ex-Dividend Date 06/13/2025
Earnings Date 05/06/2025
Market Cap Chart
Data Updated: 05/22/2025

Smruthi Organics Limited's yearly market capitalization.

Smruthi Organics Limited has seen its market value drop from ₹1.82 B to ₹1.58 B since 2020, representing a total decrease of 13.37% and an annual compound decline rate (CAGR) of 3.22%.
Date Market Cap Change (%)
05/22/2025 ₹1.58 B -2.3%
12/31/2024 ₹1.37 B -30.98%
12/29/2023 ₹1.99 B -0.83%
12/30/2022 ₹2.00 B -35.97%
12/31/2021 ₹3.13 B 71.73%
12/31/2020 ₹1.82 B

Company Profile

About Smruthi Organics Limited

Smruthi Organics Limited is a pharmaceutical company specializing in the manufacture and marketing of active pharmaceutical ingredients (APIs). The company serves markets across India, Asia, Africa, the Americas, and internationally.

Product Portfolio

  • Cardiovascular APIs: Amlodipine besilate, losartan potassium, telmisartan, s-amlodipine besilate, s-amlodipine malelate, and valsartan.
  • Anti-Diabetic APIs: Metformin HCL, vildagliptin, teneligliptin, and dapagliflozin.
  • Anti-Infective APIs: Ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate.
  • Anti-Platelets: Ticagrelor.
  • Drug Intermediates: Amlodipine base, s-amlodipine base, and phthaloyl amlodipine, along with bulk drugs.

Pipeline & Development

The company is currently developing:

  • Anti-Diabetics: Empagliflozin.
  • Anti-Platelets: Apixaban and rivaroxaban.

Business Operations

Smruthi Organics primarily exports its products to global markets. Established in 1989, the company is headquartered in Solapur, India.

Frequently Asked Questions

As of 05/22/2025, Smruthi Organics Limited (including the parent company, if applicable) has an estimated market capitalization of $18.35 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Smruthi Organics Limited global market capitalization ranking is approximately 36280 as of 05/22/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region India
Founded 1989
IPO Date n/a
Employees 303
CEO Purushotham Eaga
Sector
Industry Medicinal Chemicals and Botanical Products
Address 165-A, Balaji Bhavan
Solapur, Maharashtra 413001
India
Website https://www.smruthiorganics.com
People Also Watch
BOM-506879
3.79 3.19%
NSE-GUJTHEM
3.63 3.19%
KOSDAQ-102940
18.54 3.19%
KOSDAQ-086710
10.29 3.19%